US 8211891
Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
granted A61PA61P31/12A61P31/22
Quick answer
US patent 8211891 (Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P31/12, A61P31/22